Chong Kun Dang Pharmaceutical (185750) — Free Cash Flow Generation Index
Chong Kun Dang Pharmaceutical (185750) has a Free Cash Flow Generation Index of -3.85x as of September 2025. Free cash flow of ₩-82.69 Billion represents -4% of operating cash flow (₩21.45 Billion). See Chong Kun Dang Pharmaceutical (185750) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Chong Kun Dang Pharmaceutical Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Chong Kun Dang Pharmaceutical across 9 annual periods. Explore cash flow to debt ratio of Chong Kun Dang Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Chong Kun Dang Pharmaceutical (2016–2024)
Year-by-year Free Cash Flow Generation Index for Chong Kun Dang Pharmaceutical. For the full company profile including market capitalisation, see market cap of Chong Kun Dang Pharmaceutical.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.03x | ₩-1.81 Billion | ₩64.29 Billion | ₩66.10 Billion | ▼ -103.6% |
| 2023 | 0.78x | ₩249.35 Billion | ₩318.16 Billion | ₩68.81 Billion | ▲ +261.9% |
| 2022 | 0.22x | ₩14.67 Billion | ₩67.73 Billion | ₩44.90 Billion | ▲ +107.2% |
| 2021 | -3.02x | ₩-38.94 Billion | ₩12.90 Billion | ₩48.24 Billion | ▼ -566.4% |
| 2020 | 0.65x | ₩67.51 Billion | ₩104.32 Billion | ₩32.64 Billion | ▼ -4.6% |
| 2019 | 0.68x | ₩52.43 Billion | ₩77.29 Billion | ₩21.84 Billion | ▲ +60.8% |
| 2018 | 0.42x | ₩17.99 Billion | ₩42.63 Billion | ₩21.92 Billion | ▼ -42.9% |
| 2017 | 0.74x | ₩60.35 Billion | ₩81.67 Billion | ₩19.79 Billion | ▼ -56.1% |
| 2016 | 1.68x | ₩97.23 Billion | ₩57.79 Billion | ₩39.44 Billion | — |